Exclusive: Volvo to sell Chinese-made cars in U.S. this

New Post Public Reply Private Reply Replies (0) Message Board
BULL2222
Exclusive: Volvo to sell Chinese-made cars in U.S. this year - execs


By Norihiko Shirouzu

BEIJING (Reuters) - Volvo Car Group plans to export a Chinese-made midsize sedan this year to the United States, and is starting to weigh the possibility of building a vehicle factory in the United States, people familiar with the Chinese-owned automaker’s plans said.

Both moves would be significant for the auto industry and Volvo’s parent, Zhejiang Geely Holding Group Co [GEELY.UL]. So far, global automakers have chosen not to ship vehicles made in China to the U.S. market in any significant numbers, and efforts by Chinese automakers to export vehicles to the United States have foundered.

Volvo is also behind rivals BMW (BMWG.DE) and Mercedes (DAIGn.DE) in establishing production in the United States, which insulates the German brands from currency fluctuations.

Volvo might also export a large "strategic, flagship" sedan based on a newly developed underpinning technology, said the executives, who work for Zhejiang Geely. That car would be shipped out of China in addition to the Volvo S60L, a long wheelbase version of the S60 sedan Volvo began producing in the southwestern China city of Chengdu more than a year ago.

The moves are aimed at reviving Volvo’s momentum in the U.S. market where volume last year fell 8 percent from 2013 to 56,371 vehicles. The U.S. market, which has long been Volvo’s largest market, was replaced by China last year. China bought 81,221 Volvos in 2014, up 33 percent.

More broadly, the moves are part of Geely’s turnaround strategy for Volvo which has struggled to go beyond being a brand with an annual volume of less than a half-million vehicles. Thanks to its focus on China where the brand expanded its distribution network and product portfolio, Volvo sales volume is on the rise. It sold a total of 465,866 vehicles globally last year, up 9 percent from 2013.

LONG-STANDING GOAL

"The S60L offers class-leading rear space, something that has been consistently demanded by U.S. customers. It will be made at Volvo’s plant in Chengdu, China, and will be on show for the first time at this year’s North American International Auto Show in Detroit,” said David Ibison, a Gothenburg, Sweden-based Volvo spokesman. “The S60L forms just one part of our U.S. revival plan.”

Ibison said Volvo plans to launch seven new products by 2018 and increase U.S. sales to around 100,000 cars a year in the medium term. He declined to elaborate.

Exporting Chinese-produced mainstream passenger cars to the United States and other advanced auto markets has been a long-standing goal of China’s indigenous automakers – an objective that has largely eluded the industry.

"It would be a big breakthrough" not just for Geely but for China’s industry, said James Chao, Asia-Pacific director of consulting and research firm IHS Automotive.

"Volvo is not an indigenous Chinese brand but it is wholly Chinese-owned. Perhaps this is the model or strategy that finally works for Chinese companies trying to enter the U.S. market and other markets."

Chao added Volvo’s owner, Geely, could follow Volvo into the U.S. market with its own products, perhaps leveraging Volvo’s manufacturing and parts supply chains.

Geely's purchase of Volvo from Ford Motor Co (F.N) five years ago surprised many in the auto industry, who doubted that a relative newcomer could turn around the nearly 90-year-old Swedish business while protecting its famous brand.

The S60L was developed originally as a China-specific model to cater to wealthy Chinese consumers who prefer cars with bigger, comfortable rear seats because many of these owners have chauffeurs. Volvo expects to ship roughly 1,500 made-in-China S60L cars to the United States this year, compared with the car’s projected volume in China this year of 26,000.

The additional car Volvo plans to export to the United States, those executives said, is a flagship large sedan that might be called the S90 which uses Volvo’s new vehicle underpinning technology called "scalable platform architecture" or SPA. The S90 will be a second vehicle based on that new architecture, following the redesigned XC90 sport utility vehicle based on the same technology.

Volvo announced in late 2013 that it would produce “a large premium sedan” based on SPA at a new plant in the northeastern Chinese city of Daqing. At Daqing, Volvo began producing in September last year the XC Classic, the previous generation of the redesigned XC90.

(Editing by Joe White and Matthew Lewis)

Kandi Technologies Group Inc (KNDI) Stock Research Links

KNDI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 16

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 36

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 148

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 115

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 210

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Santander to Redeem €187.6 Million CoCos Efficiently

Updated Category News Views 146

Banco Santander Approaches €187.6 Million CoCos Redemption BANCO SANTANDER S.A. has made a significant announcement regarding the redemption of its contingent convertible securities (CoCos). This decision, which is seen as a strategic move, highlights the bank's commitment to financial efficacy and investor satisfaction. Additionally, the redemption covers a total...

Continue Reading
Revolutionizing ADC Characterization with Biozen Native Columns

Updated Category News Views 480

Transforming Biotherapeutic Characterization First of its Kind in Biotherapeutic Antibody Characterization Phenomenex Inc., a leader in separation science technology, has launched Biozen Native RP-1 and RP-5 chromatography columns. These innovative products are engineered to meet the growing demand for effective characterization methods for Antibody-Drug Conjugates...

Continue Reading
TG Therapeutics to Attend the Upcoming Global Healthcare Event

Updated Category News Views 274

Participation in Global Healthcare Conference TG Therapeutics, Inc. (NASDAQ: TGTX) is making waves as it prepares to take part in a prestigious healthcare event. Michael S. Weiss, the Chairman and CEO of the company, is scheduled to speak during the fireside chat at the Goldman Sachs Annual Global Healthcare Conference. This significant event will be hosted in Miami and...

Continue Reading
Ogury One: Revolutionizing Advertising in a Privacy-Centric World

Updated Category News Views 244

Ogury One: A New Era in Digital Advertising Ogury has launched its new client-facing platform, Ogury One, designed to revolutionize the way brands and agencies manage their advertising campaigns. As a leader in privacy-centric advertising solutions, Ogury One provides users with a comprehensive suite that facilitates seamless audience planning, activation, and reporting....

Continue Reading
Exploring Top Energy Stocks Benefiting from Industry Shifts

Updated Category News Views 124

Understanding the Shift in Energy Supply Dynamics The global energy landscape is undergoing significant changes, particularly as liquefied natural gas (LNG) supply anticipated an increase. Analysts believe that the next few years will see substantial growth in LNG, especially in response to evolving demand and new technologies. As the market adjusts, smart investors are...

Continue Reading